Table 1 Characteristics of participants (n = 76. values are absolute frequencies or means)

From: Weekly self-measurement of FEV1 and PEF and its impact on ACQ (asthma control questionnaire)-scores: 12-week observational study with 76 patients

Overall

76 (100%)

Women

57 (75%)

Diagnosed by pulmologist

58 (76%)

Diagnosed by GP

18 (24%)

Recruited by specialist

36 (47%)

Recruited by GP

40 (53%)

Smokers

14 (18%)

Mean age (overall)

45.6 years (SD = 15.4)

Mean BMI (overall)

26.0 mg/m2 (SD = 5.0)

Previous asthma training

52 (68%)

ACQ 6 week 1

 

Mean

1.3 (SD 1.0)

≤0.75

34 (45%)

0.76–1.49

19 (25%)

≥1.5

23 (30%)

FEV1 mean week 1

2.4 (SD 0.7)

FEV1 %-predicted mean week 1

80.5% (SD 19.1%)

PEF mean week 1 (mornings/evenings)

404 (SD 96) /390 (SD 98)

PEF %-predicted mean week 1

90.9% (SD 21.9%)

Asthma medication

 

ICS

63 (83%)

LABA

45 (59%)

RABA

52 (68%)

Others

11 (15%)

Controller

70 (92%)

Reliever

45 (59%)

Controller + reliever

38 (50%)

None

1 (1.3%)

  1. GP general practitioner, BMI body mass index, SD standard deviation, ACQ 6 = Asthma Control Questionnaire version with 6 items, FEV1 = forced expiratory volume in 1 second, PEF peak expiratory flow, ICS inhalative corticosteroid, LABA long-acting beta-2 agonist, RABA rapid-acting beta-2 agonist